Greenwich LifeSciences, Inc. (GLSI)
NASDAQ: GLSI · Real-Time Price · USD
10.21
-0.23 (-2.25%)
Apr 25, 2025, 10:05 AM EDT - Market open
Greenwich LifeSciences Market Cap
Greenwich LifeSciences has a market cap or net worth of $135.46 million as of April 25, 2025. Its market cap has decreased by -35.91% in one year.
Market Cap
135.46M
Enterprise Value
134.48M
1-Year Change
-35.91%
Ranking
Category
Stock Price
$10.21
Market Cap Chart
Since the IPO on September 25, 2020, Greenwich LifeSciences's market cap has increased from $68.69M to $135.46M, an increase of 97.21%. That is a compound annual growth rate of 15.99%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 23, 2025 | 130.74M | -11.43% |
| Dec 31, 2024 | 147.61M | 9.21% |
| Dec 29, 2023 | 135.16M | -30.79% |
| Dec 30, 2022 | 195.29M | -38.84% |
| Dec 31, 2021 | 319.29M | -31.08% |
| Dec 31, 2020 | 463.30M | 574.50% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 756.80B |
| UnitedHealth Group | 387.90B |
| Johnson & Johnson | 371.29B |
| AbbVie | 315.30B |
| Novo Nordisk | 276.62B |
| Abbott Laboratories | 223.28B |
| AstraZeneca | 213.42B |
| Novartis AG | 208.99B |